OR-0909 Fund I SEC Review: A Small Series Offering With Important Structural Questions
OR-0909 Fund I, a series of Contrary Capital AL, LP, appeared in SEC Form D filing records on September 25, 2026, under CIK 0002155686. Third-party filing databases identify $678,738 in incremental cash associated with the new offering. The filing provides an identifiable regulatory disclosure trail, but the available information does not establish the fund's underlying investment, realized performance, complete fee arrangements, or ultimate economic ownership. The central issue is the distinction between the individual investment series and the broader legal and administrative structure under which it operates. Investors should not assume that the financial position, assets, or investment outcomes of one series apply to another simply because they share the same umbrella name. This review examines the available filing evidence, related series records, and the specific disclosures that remain necessary to understand the offering.
Key Findings and SEC Filing Analysis
The September 25 record identifies OR-0909 Fund I as a pooled investment fund associated with Lynnwood, Washington. FormDFlow identifies the offering under Rule 506(b), while FormDs reports $678,738 in incremental cash. These figures should not be confused with a verified maximum offering amount, audited net asset value, or evidence of investment profitability. The available secondary records do not independently establish the investor count, first sale date, minimum subscription, or whether the reported capital has already been deployed. Those items require verification against the issuer's actual Form D and subscription documents.
The filing name identifies the issuer as a series of Contrary Capital AL, LP rather than a conventional stand-alone fund bearing an independent sponsor name. This distinction is important because an investor's legal and economic exposure may depend on the specific series agreement, the governing partnership documents, and the allocation of assets and liabilities. The name alone does not establish that every series has identical investment rights or obligations. It also does not establish whether OR-0909 holds a single private-company position, multiple securities, or another type of investment. Any description of its underlying portfolio without supporting documents would therefore be speculative.
Related Entities and Management Transparency
SEC records identify other series operating under the Contrary Capital AL, LP name. These include VA-0813 Fund I, CIK 0002084492, and ZE-0730 Fund II, CIK 0002086987. The latter's October 2025 Form D identifies Fund GP, LLC as its general partner and Belltower Fund Group, Ltd. among its related persons. These records establish a relevant historical entity relationship for further investigation, but they do not independently prove that the same parties control OR-0909 or that the individual series share identical investment mandates, compensation arrangements, or assets.
Another important distinction concerns the name Contrary Capital. The existence of separately named entities using that designation does not establish common ownership, management, or regulatory responsibility. In particular, OR-0909 should not automatically be associated with Contrary Capital V, L.P. or its investment adviser merely because of the shared wording. The actual relationship must be established through governing documents, related-person disclosures, and identifiable legal entities rather than branding similarities.
What We Think: The Unresolved Investment Exposure
The most material limitation in the available disclosure is the absence of independently verified underlying investment information. The reported capital figure identifies the scale of the recorded financing activity, but it does not show the acquisition price of any asset, the percentage of proceeds allocated to management or administrative costs, the timing of investment deployment, or the conditions under which investors may receive distributions. A series structure can also create additional questions concerning expense allocation, conflicts of interest, valuation methodology, and whether investors possess direct rights in underlying investments or only interests in the issuing vehicle. These are disclosure questions, not established findings of misconduct.
Before treating OR-0909 as a transparent investment opportunity, the specific offering memorandum, subscription agreement, series-level financial reporting, general-partner identification, and applicable investment restrictions should be examined together. Form D establishes a public notice of an exempt securities offering; it does not represent SEC approval of the investment, confirmation of its commercial viability, or verification of its financial projections. No independently verified adverse regulatory finding or lawsuit specific to OR-0909 has been established in the evidence reviewed here.
Final Assessment
OR-0909 Fund I has an identifiable September 2026 Form D record and a reported incremental financing amount of $678,738. Its distinguishing feature is the series structure associated with Contrary Capital AL, LP, which makes entity-level separation and management identification central to understanding the offering. The outstanding issues are the identity of the actual investment, control of the individual series, compensation arrangements, financial reporting, and investor liquidity provisions. Until those details are supported by issuer-specific documentation, neither the reported financing amount nor the existence of related SEC filings should be interpreted as evidence of investment performance or a guarantee of investor protection.
PRIMARY SOURCES
SEC EDGAR — OR-0909 Fund I: https://www.sec.gov/edgar/browse/?CIK=2155686
SEC EDGAR — Related ZE-0730 Fund II: https://www.sec.gov/Archives/edgar/data/2086987/000208698725000001/0002086987-25-000001-index.htm
SEC EDGAR — Related VA-0813 Fund I: https://www.sec.gov/Archives/edgar/data/2084492/000208449225000001/0002084492-25-000001-index.htm